Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8477470rdf:typepubmed:Citationlld:pubmed
pubmed-article:8477470lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8477470lifeskim:mentionsumls-concept:C0007570lld:lifeskim
pubmed-article:8477470lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:8477470pubmed:issue1lld:pubmed
pubmed-article:8477470pubmed:dateCreated1993-5-26lld:pubmed
pubmed-article:8477470pubmed:abstractTextIn 104 non-related children with coeliac disease, all from northern Moravia, the authors assessed the distribution of HLA antigens class I and II and compared the findings with a control group. They revealed a positive association between HLA A1 (62% sick subjects as compared 27% healthy ones), B8 (68% as compared with 18%), DR3 (66% as compared with 14%) and DQw2 (79% as compared with 23%). In HLA antigens class II there is a higher relative risk of the disease for subjects with antigens DR3 and DQw2 and a higher aetiological fraction for the investigated antigens.lld:pubmed
pubmed-article:8477470pubmed:languageczelld:pubmed
pubmed-article:8477470pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8477470pubmed:citationSubsetIMlld:pubmed
pubmed-article:8477470pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8477470pubmed:statusMEDLINElld:pubmed
pubmed-article:8477470pubmed:monthJanlld:pubmed
pubmed-article:8477470pubmed:issn0069-2328lld:pubmed
pubmed-article:8477470pubmed:authorpubmed-author:AlbertEElld:pubmed
pubmed-article:8477470pubmed:authorpubmed-author:BártováAAlld:pubmed
pubmed-article:8477470pubmed:authorpubmed-author:LenhartKKlld:pubmed
pubmed-article:8477470pubmed:authorpubmed-author:KolevVVlld:pubmed
pubmed-article:8477470pubmed:issnTypePrintlld:pubmed
pubmed-article:8477470pubmed:volume48lld:pubmed
pubmed-article:8477470pubmed:ownerNLMlld:pubmed
pubmed-article:8477470pubmed:authorsCompleteYlld:pubmed
pubmed-article:8477470pubmed:pagination5-8lld:pubmed
pubmed-article:8477470pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:meshHeadingpubmed-meshheading:8477470-...lld:pubmed
pubmed-article:8477470pubmed:year1993lld:pubmed
pubmed-article:8477470pubmed:articleTitle[HLA antigens in patients with celiac disease].lld:pubmed
pubmed-article:8477470pubmed:affiliationD?tská klinika FN, Olomouc.lld:pubmed
pubmed-article:8477470pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8477470pubmed:publicationTypeEnglish Abstractlld:pubmed